Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/carrier-screening-in-preconception-consultation-in-primary-care-0J9IwG0P9I
References (121)
-
MB Delatycki (2008)
Population screening for reproductive risk for single gene disorders in Australia: now and the futureTwin Res Hum Genet, 11
-
CJ Bell, DL Dinwiddie, NA Miller, SL Hateley, EE Ganusova, J Mudge, RJ Langley, L Zhang, CC Lee, FD Schilkey, V Sheth, JE Woodward, HE Peckham, GP Schroth, RW Kim, SF Kingsmore (2011)
Carrier testing for severe childhood recessive diseases by next-generation sequencingSci Transl Med, 3
-
H Harris, D Scotcher, N Hartley, A Wallace, D Craufurd, R Harris (1996)
Pilot study of the acceptability of cystic fibrosis carrier testing during routine antenatal consultations in general practiceBr J Gen Pract, 46
-
A Cao, MC Rosatelli, G Monni, R Galanello (2002)
Screening for thalassemia: a model of successObstet Gynecol Clin North Am, 29
-
KE Ormond, M Iris, S Banuvar, J Minogue, GJ Annas, S Elias (2007)
What do patients prefer: informed consent models for genetic carrier testingJ Genet Couns, 16
-
R Williamson (1993)
Universal community carrier screening for cystic fibrosis?Nat Genet, 3
-
C Gordon, I Walpole, SR Zubrick, C Bower (2003)
Population screening for cystic fibrosis: knowledge and emotional consequences 18 months laterAm J Med Genet, 120A
-
EW Clayton, VL Hannig, JP Pfotenhauer, RA Parker, PW Campbell, JA Phillips (1996)
Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screeningAm J Hum Genet, 58
-
M Decruyenaere, G Evers-Kiebooms, L Denayer, H Berghe (1992)
Cystic fibrosis: community knowledge and attitudes towards carrier screening and prenatal diagnosisClin Genet, 41
-
HJ Harris, D Scotcher, D Craufurd, A Wallace, R Harris (1992)
Cystic fibrosis carrier screening at first diagnosis of pregnancy in general practiceLancet, 339
-
M Welkenhuysen, G Evers-Kiebooms, M Decruyenaere, H Berghe, J Bande-Knops, V Gerven (1996)
Adolescents' attitude towards carrier testing for cystic fibrosis and its relative stability over timeEur J Hum Genet, 4
-
SA Scott, L Edelmann, L Liu, M Luo, RJ Desnick, R Kornreich (2010)
Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseasesHum Mutat, 31
-
BS Srinivasan, EA Evans, J Flannick, AS Patterson, CC Chang, T Pham, S Young, A Kaushal, J Lee, JL Jacobson, P Patrizio (2010)
A universal carrier test for the long tail of Mendelian diseaseReprod Biomed online, 21
-
S Al Arrayed, A Al Hajeri (2010)
Public awareness of sickle cell disease in BahrainAnn Saudi Med, 30
-
FA Poppelaars, L Henneman, HJ Ader, MC Cornel, RP Hermens, G Wal, LP Kate (2003)
How should preconceptional cystic fibrosis carrier screening be provided? Opinions of potential providers and the target populationComm Genet, 6
-
M Berkenstadt, L Ries-Levavi, H Cuckle, L Peleg, G Barkai (2007)
Preconceptional and prenatal screening for fragile X syndrome: experience with 40,000 testsPrenat Diagn, 27
-
S Metcalfe, R Hurworth, J Newstead, R Robins (2002)
Needs assessment study of genetics education for general practitioners in AustraliaGenet Med, 4
-
WC Spence, SH Black, L Fallon, A Maddalena, E Cummings, G Menapace-Drew, DP Bick, G Levinson, JD Schulman, PN Howard-Peebles (1996)
Molecular fragile X screening in normal populationsAm J Med Genet, 64
-
FJ Song, P Barton, V Sleightholme, GL Yao, A Fry-Smith (2003)
Screening for fragile X syndrome: a literature review and modelling studyHealth Technol Assess, 7
-
S Lévesque, C Dombrowski, ML Morel, R Rehel, JS Côté, J Bussières, K Morgan, F Rousseau (2009)
Screening and instability of FMR1 alleles in a prospective sample of 24,449 mother–newborn pairs from the general populationClin Genet, 76
-
M Ryynanen, S Heinonen, M Makkonen, E Kajanoja, A Mannermaa, K Pertti (1999)
Feasibility and acceptance of screening for fragile X mutations in low-risk pregnanciesEur J Hum Genet, 7
-
L Henneman, I Bramsen, TA Os, IE Reuling, HG Heyerman, J Laag, HM Ploeg, LP Kate (2001)
Attitudes towards reproductive issues and carrier testing among adult patients and parents of children with cystic fibrosis (CF)Prenat Diagn, 21
-
P Lakeman, AM Plass, L Henneman, PD Bezemer, MC Cornel, LP Kate (2009)
Preconceptional ancestry-based carrier couple screening for cystic fibrosis and haemoglobinopathies: what determines the intention to participate or not and actual participation?Eur J Hum Genet, 17
-
FA Poppelaars, HJ Ader, MC Cornel, L Henneman, RP Hermens, G Wal, LP Kate (2004)
Attitudes of potential providers towards preconceptional cystic fibrosis carrier screeningJ Genet Couns, 13
-
B Kerem, JM Rommens, JA Buchanan, D Markiewicz, TK Cox, A Chakravarti, M Buchwald, LC Tsui (1989)
Identification of the cystic fibrosis gene: genetic analysisScience, 245
-
TW Prior (2008)
Carrier screening for spinal muscular atrophyGenet Med, 10
-
(2011)
ACOG Committee opinion no. 486: update on carrier screening for cystic fibrosisObstet Gynecol, 117
-
KF Huang, WY Chen, YC Tsai, CC Lin, SH Chen, CY Tseng, CC Tzeng (2003)
Original article pilot screening for fragile X carrier in pregnant women of southern TaiwanJ Chin Med Assoc, 66
-
K Snow, LK Doud, R Hagerman, RG Pergolizzi, SH Erster, SN Thibodeau (1993)
Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general populationAm J Hum Genet, 53
-
SJ Gross, BA Pletcher, KG Monaghan (2008)
Carrier screening in individuals of Ashkenazi Jewish descentGenet Med, 10
-
ES Tambor, BA Bernhardt, GA Chase, RR Faden, G Geller, KJ Hofman, NA Holtzman (1994)
Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilizationAm J Hum Genet, 55
-
MJ Melancon, M Braekeleer (1996)
Adolescents' attitude towards carrier testing for cystic fibrosisEur J Hum Genet, 4
-
KW Southern, A Munck, R Pollitt, G Travert, L Zanolla, J Dankert-Roelse, C Castellani (2007)
A survey of newborn screening for cystic fibrosis in EuropeJ Cyst Fibros, 6
-
MM Kaback (2001)
Screening and prevention in Tay–Sachs disease: origins, update, and impactAdv Genet, 44
-
H Harris, D Scotcher, N Hartley, A Wallace, D Craufurd, R Harris (1993)
Cystic fibrosis carrier testing in early pregnancy by general practitionersBMJ, 306
-
Y Payne, M Williams, J Cheadle, NC Stott, M Rowlands, D Shickle, G West, L Meredith, M Goodchild, PS Harper, A Clarke (1997)
Carrier screening for cystic fibrosis in primary care: evaluation of a project in South Wales. The South Wales Cystic Fibrosis Carrier Screening Research TeamClin Genet, 51
-
TJ Musci, AB Caughey (2005)
Cost-effectiveness analysis of prenatal population-based fragile X carrier screeningAm J Obstet Gynecol, 192
-
MJ Baars, L Henneman, LP Kate (2004)
Preconceptional cystic fibrosis carrier screening: opinions of general practitioners, gynecologists, and pediatricians in the NetherlandsGenet Test, 8
-
BJ McClaren, S Metcalfe, M Aitken, J Massie, OC Ukoumunne, DJ Amor (2010)
Uptake of cystic fibrosis carrier testing in families after diagnosis through newborn screeningEur J Hum Genet, 18
-
JC Levenkron, S Loader, PT Rowley (1997)
Carrier screening for cystic fibrosis: test acceptance and one year follow-upAm J Med Genet, 73
-
L Wong, E George, J-A Tan (2011)
A holistic approach to education programs in thalassemia for a multi-ethnic population: consideration of perspectives, attitudes, and perceived needsJ Comm Genet, 2
-
K Muralidharan, RB Wilson, S Ogino, N Nagan, C Curtis, I Schrijver (2011)
Population carrier screening for spinal muscular atrophy a position statement of the association for molecular pathologyJ Mol Diagn, 13
-
NE Cousens, CL Gaff, SA Metcalfe, MB Delatycki (2010)
Carrier screening for beta-thalassaemia: a review of international practiceEur J Hum Genet, 18
-
TW Prior, PJ Snyder, BD Rink, DK Pearl, RE Pyatt, DC Mihal, T Conlan, B Schmalz, L Montgomery, K Ziegler, C Noonan, S Hashimoto, S Garner (2010)
Newborn and carrier screening for spinal muscular atrophyAm J Med Genet A, 152A
-
S Metcalfe, A Jacques, A Archibald, T Burgess, V Collins, A Henry, K McNamee, L Sheffield, H Slater, S Wake, J Cohen (2008)
A model for offering carrier screening for fragile X syndrome to nonpregnant women: results from a pilot studyGenet Med, 10
-
JR Riordan, JM Rommens, B Kerem, N Alon, R Rozmahel, Z Grzelczak, J Zielenski, S Lok, N Plavsic, JL Chou (1989)
Identification of the cystic fibrosis gene: cloning and characterization of complementary DNAScience, 245
-
B Finucane (1996)
Should all pregnant women be offered carrier testing for fragile X syndrome?Clin Obstet Gynecol, 39
-
S Jacquemont, RJ Hagerman, M Leehey, J Grigsby, L Zhang, JA Brunberg, C Greco, V Des Portes, T Jardini, R Levine, E Berry-Kravis, WT Brown, S Schaeffer, J Kissel, F Tassone, PJ Hagerman (2003)
Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlatesAm J Hum Genet, 72
-
TJ Musci (2005)
Screening for single gene genetic diseaseGynecol Obstet Invest, 60
-
TW Prior (2010)
Spinal muscular atrophy: a time for screeningCurr Opin Pediatr, 22
-
H Bekker, G Denniss, M Modell, M Bobrow, T Marteau (1994)
The impact of population based screening for carriers of cystic fibrosisJ Med Genet, 31
-
BA Bernhardt, GA Chase, RR Faden, G Geller, KJ Hofman, ES Tambor, NA Holtzman (1996)
Educating patients about cystic fibrosis carrier screening in a primary care settingArch Fam Med, 5
-
EK Watson, R Williamson, J Chapple (1991)
Attitudes to carrier screening for cystic fibrosis: a survey of health care professionals, relatives of sufferers and other members of the publicBr J Gen Pract, 41
-
SS Weinreich, ES Lange-de Klerk, F Rijmen, MC Cornel, M Kinderen, AM Plass (2009)
Raising awareness of carrier testing for hereditary haemoglobinopathies in high-risk ethnic groups in the Netherlands: a pilot study among the general public and primary care providersBMC Public Health, 9
-
FA Poppelaars, G Wal, JC Braspenning, MC Cornel, L Henneman, MW Langendam, LP Kate (2003)
Possibilities and barriers in the implementation of a preconceptional screening programme for cystic fibrosis carriers: a focus group studyPublic Health, 117
-
L Basel-Vanagaite, E Taub, V Drasinover, N Magal, A Brudner, J Zlotogora, M Shohat (2008)
Genetic carrier screening for spinal muscular atrophy and spinal muscular atrophy with respiratory distress 1 in an isolated population in IsraelGenet Test, 12
-
L Locock, J Kai (2008)
Parents' experiences of universal screening for haemoglobin disorders: implications for practice in a new genetics eraBr J Gen Pract, 58
-
M Mennie, H Campbell, WA Liston, DJ Brock (1998)
Attitudes of general practitioners to screening for cystic fibrosisJ Med Screen, 5
-
NE Hartley, D Scotcher, H Harris, P Williamson, A Wallace, D Craufurd, R Harris (1997)
The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GPJ Med Genet, 34
-
SL Nolin, WT Brown, A Glicksman, GE Houck, AD Gargano, A Sullivan, V Biancalana, K Brondum-Nielsen, H Hjalgrim, E Holinski-Feder, F Kooy, J Longshore, J Macpherson, JL Mandel, G Matthijs, F Rousseau, P Steinbach, ML Vaisanen, H Koskull, SL Sherman (2003)
Expansion of the fragile X CGG repeat in females with premutation or intermediate allelesAm J Hum Genet, 72
-
L Henneman, I Bramsen, HM Ploeg, LP Kate (2002)
Preconception cystic fibrosis carrier couple screening: impact, understanding, and satisfactionGenet Test, 6
-
GE Palomaki (1994)
Population based prenatal screening for the fragile X syndromeJ Med Screen, 1
-
J Kallinen, K Marin, S Heinonen, A Mannermaa, A Palotie, M Ryynanen (2001)
Wide scope prenatal diagnosis at Kuopio University Hospital 1997–1998: integration of gene tests and fetal karyotypingBJOG, 108
-
S Otsuka, Y Sakamoto, H Siomi, M Itakura, K Yamamoto, H Matumoto, T Sasaki, N Kato, E Nanba (2010)
Fragile X carrier screening and FMR1 allele distribution in the Japanese populationBrain Dev, 32
-
LS Chen, P Goodson (2007)
Factors affecting decisions to accept or decline cystic fibrosis carrier testing/screening: a theory-guided systematic reviewGenet Med, 9
-
MF Myers, BA Bernhardt, ES Tambor, NA Holtzman (1994)
Involving consumers in the development of an educational program for cystic fibrosis carrier screeningAm J Hum Genet, 54
-
J Massie, V Petrou, R Forbes, L Curnow, L Ioannou, D Sart, A Bankier, M Delatycki (2009)
Population-based carrier screening for cystic fibrosis in Victoria: the first three years experienceAust N Z J Obstet Gynaecol, 49
-
FA Poppelaars, L Henneman, HJ Ader, MC Cornel, RP Hermens, G Wal, LP Kate (2004)
Preconceptional cystic fibrosis carrier screening: attitudes and intentions of the target populationGenet Test, 8
-
FM Hantash, DM Goos, B Crossley, B Anderson, K Zhang, W Sun, CM Strom (2011)
FMR1 premutation carrier frequency in patients undergoing routine population-based carrier screening: insights into the prevalence of fragile X syndrome, fragile X-associated tremor/ataxia syndrome, and fragile X-associated primary ovarian insufficiency in the United StatesGenet Med, 13
-
WW Grody, GR Cutting, KW Klinger, CS Richards, MS Watson, RJ Desnick (2001)
Laboratory standards and guidelines for population-based cystic fibrosis carrier screeningGenet Med, 3
-
N Qureshi, S Armstrong, B Modell (2006)
GPs' opinions of their role in prenatal genetic services: a cross-sectional surveyFam Pract, 23
-
KL Meadows, SL Sherman (1996)
Fragile X syndrome: examination of issues pertaining to population-based screeningScreening, 4
-
JM Rommens, MC Iannuzzi, B Kerem, ML Drumm, G Melmer, M Dean, R Rozmahel, JL Cole, D Kennedy, N Hidaka (1989)
Identification of the cystic fibrosis gene: chromosome walking and jumpingScience, 245
-
CM Strom, B Crossley, A Buller-Buerkle, M Jarvis, F Quan, M Peng, K Muralidharan, V Pratt, JB Redman, W Sun (2011)
Cystic fibrosis testing 8 years on: lessons learned from carrier screening and sequencing analysisGenet Med, 13
-
J Zlotogora, R Carmi, B Lev, SA Shalev (2009)
A targeted population carrier screening program for severe and frequent genetic diseases in IsraelEur J Hum Genet, 17
-
S Sherman, BA Pletcher, DA Driscoll (2005)
Fragile X syndrome: diagnostic and carrier testingGenet Med, 7
-
AA Gason, E Sheffield, A Bankier, MA Aitken, S Metcalfe, K Barlow Stewart, MB Delatycki (2003)
Evaluation of a Tay–Sachs disease screening programClin Genet, 63
-
JH Fanos, KA Spangner, TJ Musci (2006)
Attitudes toward prenatal screening and testing for Fragile XGenet Med, 8
-
M Modell, B Wonke, E Anionwu, M Khan, SS Tai, M Lloyd, B Modell (1998)
A multidisciplinary approach for improving services in primary care: randomised controlled trial of screening for haemoglobin disordersBMJ, 317
-
R Pesso, M Berkenstadt, H Cuckle, E Gak, L Peleg, M Frydman, G Barkai (2000)
Screening for fragile X syndrome in women of reproductive agePrenat Diagn, 20
-
M Honnor, SR Zubrick, I Walpole, C Bower, J Goldblatt (2000)
Population screening for cystic fibrosis in Western Australia: community responseAm J Med Genet, 93
-
(2009)
ACOG Committee opinion no. 432: spinal muscular atrophyObstet Gynecol, 113
-
S Ahmed, J Green, J Hewison (2005)
Antenatal thalassaemia carrier testing: women's perceptions of “information” and “consent”J Med Screen, 12
-
B Godard, L Kate, G Evers-Kiebooms, S Ayme (2003)
Population genetic screening programmes: principles, techniques, practices, and policiesEur J Hum Genet, 11
-
MF Wildhagen, TA Os, JJ Polder, LP Kate, JD Habbema (1998)
Explorative study of costs, effects and savings of screening for female fragile X premutation and full mutation carriers in the general populationComm Genet, 1
-
BS Wilfond, N Fost (1990)
The cystic fibrosis gene: medical and social implications for heterozygote detectionJAMA, 263
-
P Borry, L Henneman, P Lakeman, LP Kate, MC Cornel, HC Howard (2011)
Preconceptional genetic carrier testing and the commercial offer directly-to-consumersHum Reprod, 26
-
JA Dodge, PA Lewis, M Stanton, J Wilsher (2007)
Cystic fibrosis mortality and survival in the UK: 1947–2003Eur Respir J, 29
-
SJ Maxwell, G Kyne, C Molster, NM Barker, J Ormsby, P O'Leary (2011)
Perceptions of population cystic fibrosis prenatal and preconception carrier screening among individuals with cystic fibrosis and their family membersGenet Test Mol Biomarkers, 15
-
L Henneman, I Bramsen, L Kempen, MB Acker, G Pals, HE Horst, HJ Ader, HM Ploeg, LP Kate (2003)
Offering preconceptional cystic fibrosis carrier couple screening in the absence of established preconceptional care servicesComm Genet, 6
-
M Angastiniotis, B Modell, P Englezos, V Boulyjenkov (1995)
Prevention and control of haemoglobinopathiesBull World Health Organ, 73
-
A Cronister, M DiMaio, MJ Mahoney, AE Donnenfeld, S Hallam (2005)
Fragile X syndrome carrier screening in the prenatal genetic counseling settingGenet Med, 7
-
RJ Hagerman, M Leehey, W Heinrichs, F Tassone, R Wilson, J Hills, J Grigsby, B Gage, PJ Hagerman (2001)
Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile XNeurology, 57
-
BP O'Sullivan, SD Freedman (2009)
Cystic fibrosisLancet, 373
-
YN Su, CC Hung, SY Lin, FY Chen, JP Chern, C Tsai, TS Chang, CC Yang, H Li, HN Ho, CN Lee (2011)
Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005–2009: a prospective population-based cohort studyPLoS One, 6
-
RR Faden, ES Tambor, GA Chase, G Geller, KJ Hofman, NA Holtzman (1994)
Attitudes of physicians and genetics professionals toward cystic fibrosis carrier screeningAm J Med Genet, 50
-
A Anido, LM Carlson, L Taft, SL Sherman (2005)
Women's attitudes toward testing for fragile X carrier status: a qualitative analysisJ Genet Couns, 14
-
M Modell (1993)
Screening for carriers of cystic fibrosis—a general practitioner's perspectiveBMJ, 307
-
M Boulton, C Cummings, R Williamson (1996)
The views of general practitioners on community carrier screening for cystic fibrosisBr J Gen Pract, 46
-
JR Botkin, S Alemagno (1992)
Carrier screening for cystic fibrosis: a pilot study of the attitudes of pregnant womenAm J Public Health, 82
-
L Henneman, I Bramsen, HM Ploeg, HJ Ader, HE Horst, JJ Gille, LP Kate (2001)
Participation in preconceptional carrier couple screening: characteristics, attitudes, and knowledge of both partnersJ Med Genet, 38
-
H Toledano-Alhadef, L Basel-Vanagaite, N Magal, B Davidov, S Ehrlich, V Drasinover, E Taub, GJ Halpern, N Ginott, M Shohat (2001)
Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in IsraelAm J Hum Genet, 69
-
YH Fu, DP Kuhl, A Pizzuti, M Pieretti, JS Sutcliffe, S Richards, AJ Verkerk, JJ Holden, RG Fenwick, ST Warren (1991)
Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradoxCell, 67
-
E Geva, Y Yaron, R Shomrat, A Ben-Yehuda, S Zabari, H Peretz, T Naiman, H Yeger, A Orr-Urtreger (2000)
The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X familiesGenet Test, 4
-
BJ McClaren, MB Delatycki, V Collins, SA Metcalfe, M Aitken (2008)
‘It is not in my world’: an exploration of attitudes and influences associated with cystic fibrosis carrier screeningEur J Hum Genet, 16
-
SL Nolin, FA Lewis, LL Ye, GE Houck, AE Glicksman, P Limprasert, SY Li, N Zhong, AE Ashley, E Feingold, SL Sherman, WT Brown (1996)
Familial transmission of the FMR1 CGG repeatAm J Hum Genet, 59
-
H Cuckle, P Quirke, I Sehmi, F Lewis, J Murray, D Cross, P Cuckle, B Ozols (1996)
Antenatal screening for cystic fibrosisBr J Obstet Gynaecol, 103
-
MK Hill, AD Archibald, J Cohen, SA Metcalfe (2010)
A systematic review of population screening for fragile X syndromeGenet Med, 12
-
(2005)
ACOG Committee opinion. Number 325, December 2005. Update on carrier screening for cystic fibrosisObstet Gynecol, 106
-
AD Archibald, AM Jaques, S Wake, VR Collins, J Cohen, SA Metcalfe (2009)
“It's something I need to consider”: decisions about carrier screening for fragile X syndrome in a population of non-pregnant womenAm J Med Genet A, 149A
-
JJ Mitchell, A Capua, C Clow, CR Scriver (1996)
Twenty-year outcome analysis of genetic screening programs for Tay–Sachs and beta-thalassemia disease carriers in high schoolsAm J Hum Genet, 59
-
L Heredero-Baute (2004)
Community-based program for the diagnosis and prevention of genetic disorders in CubaPubl Health Genomics, 7
-
A Anido, LM Carlson, SL Sherman (2007)
Attitudes toward fragile x mutation carrier testing from women identified in a general population surveyJ Genet Couns, 16
-
S Loader, P Caldwell, A Kozyra, JC Levenkron, CD Boehm, HH Kazazian, PT Rowley (1996)
Cystic fibrosis carrier population screening in the primary care settingAm J Hum Genet, 59
-
M Angastiniotis, B Modell (1998)
Global epidemiology of hemoglobin disordersAnn N Y Acad Sci, 850
-
H Bekker, M Modell, G Denniss, A Silver, C Mathew, M Bobrow, T Marteau (1993)
Uptake of cystic fibrosis testing in primary care: supply push or demand pull?BMJ, 306
-
EK Watson, E Mayall, J Chapple, M Dalziel, K Harrington, C Williams, R Williamson (1991)
Screening for carriers of cystic fibrosis through primary health care servicesBMJ, 303
-
A McConkie-Rosell, L Abrams, B Finucane, A Cronister, LW Gane, SM Coffey, S Sherman, LM Nelson, E Berry-Kravis, D Hessl, S Chiu, N Street, A Vatave, RJ Hagerman (2007)
Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disordersJ Genet Couns, 16
-
A McConkie-Rosell, B Finucane, A Cronister, L Abrams, RL Bennett, BJ Pettersen (2005)
Genetic counseling for fragile X syndrome: updated recommendations of the national society of genetic counselorsJ Genet Couns, 14
-
LP Wong, E George, JA Tan (2011)
Public perceptions and attitudes toward thalassaemia: influencing factors in a multi-racial populationBMC Public Health, 11
-
L Ioannou, J Massie, V Collins, B McClaren, MB Delatycki (2010)
Population-based genetic screening for cystic fibrosis: attitudes and outcomesPubl Health Genomics, 13
- Publisher
- Springer Journals
- Copyright
- Copyright © 2011 by Springer-Verlag
- Subject
- Biomedicine; Human Genetics; Public Health; Epidemiology; Gene Therapy; Gene Function
- ISSN
- 1868-310X
- eISSN
- 1868-6001
- DOI
- 10.1007/s12687-011-0071-z
- pmid
- 22183783
- Publisher site
- See Article on Publisher Site
Abstract
Discussing carrier screening during preconception consultation in primary care has a number of advantages in terms of promoting autonomy and enabling the greatest range of reproductive choices. For those with a family history of an inherited condition, this ought to be a routine discussion; however, this can be expanded to include the wider population, especially for those conditions for which carrier frequencies are considered relatively common. There is published literature from around the world regarding experiences with carrier screening in primary care for cystic fibrosis, haemoglobinopathies, fragile X syndrome, Tay–Sachs disease and spinal muscular atrophy, although many of these have tended to focus on consultations during rather than before pregnancy. Overall, these studies reveal that population carrier screening is well received by the participants with apparent minimal psychosocial harms; however, challenges exist in terms of approaches to ensure couples receive adequate information to make personally relevant decisions and for ongoing health professional engagement.
Journal
Journal of Community Genetics – Springer Journals
Published: Dec 20, 2011